Direct effects of hepatitis C virus on the lymphoid cells

World Journal of Gastroenterology

Volumn 19, Issue 44, 2013, Pages 7889-7895

  Kondo, Yasuteru ^a   Shimosegawa, Tooru ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

B cell; Hepatitis C virus; Immunology; Lymphotropism; T cell

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; B LYMPHOCYTE RECEPTOR; CD14 ANTIGEN; CD16 ANTIGEN; CD19 ANTIGEN; CD27 ANTIGEN; CD81 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; PEGINTERFERON; RIBAVIRIN; STAT3 PROTEIN;

ARTICLE; AUTOIMMUNE DISEASE; CARCINOGENESIS; CELLULAR IMMUNITY; GENE MUTATION; GENETIC TRANSCRIPTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMORAL IMMUNITY; IMMUNE EVASION; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; LIVER CELL CARCINOMA; LYMPHOID CELL; MIXED INFECTION; NONHUMAN;

B CELL; HEPATITIS C VIRUS; IMMUNOLOGY; LYMPHOTROPISM; T CELL;

ANIMALS; AUTOIMMUNE DISEASES; CRYOGLOBULINEMIA; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNE EVASION; LYMPHOCYTES; LYMPHOMA;

EID: 84888597007     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i44.7889     Document Type: Article

References (81)

1. Hajarizadeh B, Grebely J, Dore GJ. Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol 2013; 10: 553-562 [PMID: 23817321 DOI: 10.1038/nrgastro.2013.107]
2. Zalesak M, Francis K, Gedeon A, Gillis J, Hvidsten K, Kidder P, Li H, Martyn D, Orne L, Smith A, Kwong A. Current and future disease progression of the chronic HCV population in the United States. PLoS One 2013; 8: e63959 [PMID: 23704962 DOI: 10.1371/journal.pone.0063959]
3. Medina J, García-Buey L, Moreno-Otero R. Hepatitis C virus-related extra-hepatic disease--aetiopathogenesis and management. Aliment Pharmacol Ther 2004; 20: 129-141 [PMID: 15233692 DOI: 10.1111/j.1365-2036.2004.01919.x]
4. De Vita S, Sansonno D, Dolcetti R, Ferraccioli G, Carbone A, Cornacchiulo V, Santini G, Crovatto M, Gloghini A, Dammacco F, Boiocchi M. Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. Blood 1995; 86: 1887-1892 [PMID: 7655017]
5. Karavattathayyil SJ, Kalkeri G, Liu HJ, Gaglio P, Garry RF, Krause JR, Dash S. Detection of hepatitis C virus RNA sequences in B-cell non-Hodgkin lymphoma. Am J Clin Pathol 2000; 113: 391-398 [PMID: 10705820 DOI: 10.1309/REV9FDTM-5NGC-HBWY]
6. Akbayir N, Gökdemir G, Mansur T, Sökmen M, Gündüz S, Alkim C, Barutcuoglu B, Erdem L. Is there any relationship between hepatitis C virus and vitiligo? J Clin Gastroenterol 2004; 38: 815-817 [PMID: 15365412]
7. Simula MP, Caggiari L, Gloghini A, De Re V. HCV-related immunocytoma and type II mixed cryoglobulinemia-associated autoantigens. Ann N Y Acad Sci 2007; 1110: 121-130 [PMID: 17911427 DOI: 10.1196/annals.1423.014]
8. Kondo Y, Ueno Y, Kakazu E, Kobayashi K, Shiina M, Tamai K, Machida K, Inoue J, Wakui Y, Fukushima K, Obara N, Kimura O, Shimosegawa T. Lymphotropic HCV strain can infect human primary naïve CD4+ cells and affect their proliferation and IFN-γ secretion activity. J Gastroenterol 2011; 46: 232-241 [PMID: 20714907 DOI: 10.1007/ s00535-010-0297-2]
9. Fukuhara T, Kambara H, Shiokawa M, Ono C, Katoh H, Morita E, Okuzaki D, Maehara Y, Koike K, Matsuura Y. Expression of microRNA miR-122 facilitates an efficient replication in nonhepatic cells upon infection with hepatitis C virus. J Virol 2012; 86: 7918-7933 [PMID: 22593164 DOI: 10.1128/JVI.00567-12]
10. Lunel F, Musset L. Mixed cryoglobulinemia and hepatitis C virus infection. Minerva Med 2001; 92: 35-42 [PMID: 11317137]
11. Rowan BP, Smith A, Gleeson D, Hunt LP, Warnes TW. Hepatitis C virus in autoimmune liver disease in the UK: aetiological agent or artefact? Gut 1994; 35: 542-546 [PMID: 8174994 DOI: 10.1136/gut.35.4.542]
12. Eddleston AL. Hepatitis C infection and autoimmunity. J Hepatol 1996; 24: 55-60 [PMID: 8836890]
13. Manns MP, Rambusch EG. Autoimmunity and extrahepatic manifestations in hepatitis C virus infection. J Hepatol 1999; 31 Suppl 1: 39-42 [PMID: 10622558 DOI: 10.1016/ S0168-8278(99)80372-9]
14. Machida K, Cheng KT, Sung VM, Shimodaira S, Lindsay KL, Levine AM, Lai MY, Lai MM. Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc Natl Acad Sci USA 2004; 101: 4262-4267 [PMID: 14999097 DOI: 10.1073/pnas.0303971101]
15. Machida K, Cheng KT, Sung VM, Levine AM, Foung S, Lai MM. Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6. J Virol 2006; 80: 866-874 [PMID: 16378988 DOI: 10.1128/JVI.80.2.866-874.2006]
16. Kondo Y, Iwata T, Haga T, Kimura O, Ninomiya M, Kakazu E, Kogure T, Morosawa T, Aiba S, Shimosegawa T. Eradication of hepatitis C virus could improve immunological status and pyoderma gangrenosum-like lesions. Hepatol Res 2013; Epub ahead of print [PMID: 23551965 DOI: 10.1111/ hepr.12102]
17. Machida K, Cheng KT, Pavio N, Sung VM, Lai MM. Hepatitis C virus E2-CD81 interaction induces hypermutation of the immunoglobulin gene in B cells. J Virol 2005; 79: 8079-8089 [PMID: 15956553 DOI: 10.1128/JVI.79.13.8079-808 9.2005]
18. Baré P, Massud I, Parodi C, Belmonte L, García G, Nebel MC, Corti M, Pinto MT, Bianco RP, Bracco MM, Campos R, Ares BR. Continuous release of hepatitis C virus (HCV) by peripheral blood mononuclear cells and B-lymphoblastoid cell-line cultures derived from HCV-infected patients. J Gen Virol 2005; 86: 1717-1727 [PMID: 15914850 DOI: 10.1099/ vir.0.80882-0]
19. Laskus T, Radkowski M, Piasek A, Nowicki M, Horban A, Cianciara J, Rakela J. Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes. J Infect Dis 2000; 181: 442-448 [PMID: 10669324 DOI: 10.1086/315283]
20. MacParland SA, Pham TN, Guy CS, Michalak TI. Hepatitis C virus persisting after clinically apparent sustained virological response to antiviral therapy retains infectivity in vitro. Hepatology 2009; 49: 1431-1441 [PMID: 19177592 DOI: 10.1002/hep.22802]
21. Pal S, Sullivan DG, Kim S, Lai KK, Kae J, Cotler SJ, Carithers RL, Wood BL, Perkins JD, Gretch DR. Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism. Gastroenterology 2006; 130: 1107-1116 [PMID: 16618405 DOI: 10.1053/ j.gastro.2005.12.039]
22. Pham TN, Coffin CS, Michalak TI. Occult hepatitis C virus infection: what does it mean? Liver Int 2010; 30: 502-511 [PMID: 20070513 DOI: 10.1111/j.1478-3231.2009.02193.x]
23. Radkowski M, Gallegos-Orozco JF, Jablonska J, Colby TV, Walewska-Zielecka B, Kubicka J, Wilkinson J, Adair D, Rakela J, Laskus T. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 2005; 41: 106-114 [PMID: 15619235 DOI: 10.1002/hep.20518]
24. Machida K, Liu JC, McNamara G, Levine A, Duan L, Lai MM. Hepatitis C virus causes uncoupling of mitotic checkpoint and chromosomal polyploidy through the Rb pathway. J Virol 2009; 83: 12590-12600 [PMID: 19793824 DOI: 10.1128/JVI.02643-08]
25. Kondo Y, Machida K, Liu HM, Ueno Y, Kobayashi K, Wakita T, Shimosegawa T, Lai MM. Hepatitis C virus infection of T cells inhibits proliferation and enhances fas-mediated apoptosis by down-regulating the expression of CD44 splicing variant 6. J Infect Dis 2009; 199: 726-736 [PMID: 19199548 DOI: 10.1086/596739]
26. Kondo Y, Sung VM, Machida K, Liu M, Lai MM. Hepatitis C virus infects T cells and affects interferon-gamma signaling in T cell lines. Virology 2007; 361: 161-173 [PMID: 17175001 DOI: 10.1016/j.virol.2006.11.009]
27. Machida K, Kondo Y, Huang JY, Chen YC, Cheng KT, Keck Z, Foung S, Dubuisson J, Sung VM, Lai MM. Hepatitis C virus (HCV)-induced immunoglobulin hypermutation reduces the affinity and neutralizing activities of antibodies against HCV envelope protein. J Virol 2008; 82: 6711-6720 [PMID: 18417597]
28. Goutagny N, Fatmi A, De Ledinghen V, Penin F, Couzigou P, Inchauspé G, Bain C. Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection. J Infect Dis 2003; 187: 1951-1958 [PMID: 12792872 DOI: 10.1086/375350]
29. Sung VM, Shimodaira S, Doughty AL, Picchio GR, Can H, Yen TS, Lindsay KL, Levine AM, Lai MM. Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection. J Virol 2003; 77: 2134-2146 [PMID: 12525648 DOI: 10.1128/JVI.77.3.2134-2146.2003]
30. Muratori L, Gibellini D, Lenzi M, Cataleta M, Muratori P, Morelli MC, Bianchi FB. Quantification of hepatitis C virusinfected peripheral blood mononuclear cells by in situ reverse transcriptase-polymerase chain reaction. Blood 1996; 88: 2768-2774 [PMID: 8839874]
31. Laskus T, Radkowski M, Wang LF, Vargas H, Rakela J. The presence of active hepatitis C virus replication in lymphoid tissue in patients coinfected with human immunodeficiency virus type 1. J Infect Dis 1998; 178: 1189-1192 [PMID: 9806058 DOI: 10.1086/515682]
32. Qu J, Zhang Q, Li Y, Liu W, Chen L, Zhu Y, Wu J. The Tat protein of human immunodeficiency virus-1 enhances hepatitis C virus replication through interferon gamma-inducible protein-10. BMC Immunol 2012; 13: 15 [PMID: 22471703 DOI: 10.1186/1471-2172-13-15]
33. de Felipe B, Leal M, Soriano-Sarabia N, Gutiérrez A, López-Cortés L, Molina-Pinelo S, Vallejo A. HCV RNA in peripheral blood cell subsets in HCV-HIV coinfected patients at the end of PegIFN/RBV treatment is associated with virologic relapse. J Viral Hepat 2009; 16: 21-27 [PMID: 18761604 DOI: 10.1111/j.1365-2893.2008.01043.x]
34. Ito M, Masumi A, Mochida K, Kukihara H, Moriishi K, Matsuura Y, Yamaguchi K, Mizuochi T. Peripheral B cells may serve as a reservoir for persistent hepatitis C virus infection. J Innate Immun 2010; 2: 607-617 [PMID: 20714117]
35. Chary A, Winters MA, Eisen R, Knight TH, Asmuth DM, Holodniy M. Quantitation of hepatitis C virus RNA in peripheral blood mononuclear cells in HCV-monoinfection and HIV/HCV-coinfection. J Med Virol 2012; 84: 431-437 [PMID: 22246828 DOI: 10.1002/jmv.23210]
36. Mizuochi T, Ito M, Takai K, Yamaguchi K. Peripheral blood memory B cells are resistant to apoptosis in chronic hepatitis C patients. Virus Res 2011; 155: 349-351 [PMID: 20875472 DOI: 10.1016/j.virusres.2010.09.017]
37. Pham TN, King D, Macparland SA, McGrath JS, Reddy SB, Bursey FR, Michalak TI. Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis C and occult infection. Gastroenterology 2008; 134: 812-822 [PMID: 18243182 DOI: 10.1053/j.gastro.2007.12.011]
38. Pham TN, Macparland SA, Coffin CS, Lee SS, Bursey FR, Michalak TI. Mitogen-induced upregulation of hepatitis C virus expression in human lymphoid cells. J Gen Virol 2005; 86: 657-666 [PMID: 15722526 DOI: 10.1099/vir.0.80624-0]
39. Sarhan MA, Pham TN, Chen AY, Michalak TI. Hepatitis C virus infection of human T lymphocytes is mediated by CD5. J Virol 2012; 86: 3723-3735 [PMID: 22278227 DOI: 10.1128/JVI.06956-11]
40. Sarhan MA, Chen AY, Michalak TI. Differential expression of candidate virus receptors in human T lymphocytes prone or resistant to infection with patient-derived hepatitis C virus. PLoS One 2013; 8: e62159 [PMID: 23626783 DOI: 10.1371/journal.pone.0062159]
41. Coquillard G, Patterson BK. Determination of hepatitis C virus-infected, monocyte lineage reservoirs in individuals with or without HIV coinfection. J Infect Dis 2009; 200: 947-954 [PMID: 19678757 DOI: 10.1086/605476]
42. Laskus T, Radkowski M, Jablonska J, Kibler K, Wilkinson J, Adair D, Rakela J. Human immunodeficiency virus facilitates infection/replication of hepatitis C virus in native human macrophages. Blood 2004; 103: 3854-3859 [PMID: 14739225 DOI: 10.1182/blood-2003-08-2923]
43. Ducoulombier D, Roque-Afonso AM, Di Liberto G, Penin F, Kara R, Richard Y, Dussaix E, Féray C. Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes. Hepatology 2004; 39: 817-825 [PMID: 14999702 DOI: 10.1002/hep.20087]
44. Navas MC, Fuchs A, Schvoerer E, Bohbot A, Aubertin AM, Stoll-Keller F. Dendritic cell susceptibility to hepatitis C virus genotype 1 infection. J Med Virol 2002; 67: 152-161 [PMID: 11992576 DOI: 10.1002/jmv.2204]
45. Sansonno D, Lotesoriere C, Cornacchiulo V, Fanelli M, Gatti P, Iodice G, Racanelli V, Dammacco F. Hepatitis C virus infection involves CD34(+) hematopoietic progenitor cells in hepatitis C virus chronic carriers. Blood 1998; 92: 3328-3337 [PMID: 9787170]
46. Lerat H, Rumin S, Habersetzer F, Berby F, Trabaud MA, Trépo C, Inchauspé G. In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype, and cell phenotype. Blood 1998; 91: 3841-3849 [PMID: 9573022]
47. Ferri C, Caracciolo F, Zignego AL, La Civita L, Monti M, Longombardo G, Lombardini F, Greco F, Capochiani E, Mazzoni A. Hepatitis C virus infection in patients with nonHodgkin's lymphoma. Br J Haematol 1994; 88: 392-394 [PMID: 7803287 DOI: 10.1111/j.1365-2141.1994.tb05036.x]
48. Gisbert JP, García-Buey L, Pajares JM, Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology 2003; 125: 1723-1732 [PMID: 14724825 DOI: 10.1053/j.gastro.2003.09.025]
49. Hausfater P, Cacoub P, Sterkers Y, Thibault V, Amoura Z, Nguyen L, Ghillani P, Leblond V, Piette JC. Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France. Am J Hematol 2001; 67: 168-171 [PMID: 11391713 DOI: 10.1002/ajh.1101]
50. Matsuo K, Kusano A, Sugumar A, Nakamura S, Tajima K, Mueller NE. Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies. Cancer Sci 2004; 95: 745-752 [PMID: 15471561 DOI: 10.1111/j.1349-7006.2004.tb03256.x]
51. Monti G, Pioltelli P, Saccardo F, Campanini M, Candela M, Cavallero G, De Vita S, Ferri C, Mazzaro C, Migliaresi S, Ossi E, Pietrogrande M, Gabrielli A, Galli M, Invernizzi F. Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virusrelated symptomatic mixed cryoglobulinemias. Arch Intern Med 2005; 165: 101-105 [PMID: 15642884 DOI: 10.1001/ archinte.165.1.101]
52. Rosa D, Saletti G, De Gregorio E, Zorat F, Comar C, D'Oro U, Nuti S, Houghton M, Barnaba V, Pozzato G, Abrignani S. Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc Natl Acad Sci USA 2005; 102: 18544-18549 [PMID: 16339892 DOI: 10.1073/pnas.0509402102]
53. Feldmann G, Nischalke HD, Nattermann J, Banas B, Berg T, Teschendorf C, Schmiegel W, Dührsen U, Halangk J, Iwan A, Sauerbruch T, Caselmann WH, Spengler U. Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma. Clin Cancer Res 2006; 12: 4491-4498 [PMID: 16899594 DOI: 10.1158/1078-0432.CCR-06-0154]
54. Peveling-Oberhag J, Crisman G, Schmidt A, Döring C, Lucioni M, Arcaini L, Rattotti S, Hartmann S, Piiper A, Hofmann WP, Paulli M, Küppers R, Zeuzem S, Hansmann ML. Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection. Leukemia 2012; 26: 1654-1662 [PMID: 22307176 DOI: 10.1038/leu.2012.29]
55. Machida K, Cheng KT, Lai CK, Jeng KS, Sung VM, Lai MM. Hepatitis C virus triggers mitochondrial permeability transition with production of reactive oxygen species, leading to DNA damage and STAT3 activation. J Virol 2006; 80: 7199-7207 [PMID: 16809325 DOI: 10.1128/JVI.00321-06]
56. Machida K, Cheng KT, Sung VM, Lee KJ, Levine AM, Lai MM. Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes. J Virol 2004; 78: 8835-8843 [PMID: 15280491 DOI: 10.1128/ JVI.78.16.8835-8843.2004]
57. Machida K, Tsukiyama-Kohara K, Sekiguch S, Seike E, Tóne S, Hayashi Y, Tobita Y, Kasama Y, Shimizu M, Takahashi H, Taya C, Yonekawa H, Tanaka N, Kohara M. Hepatitis C virus and disrupted interferon signaling promote lymphoproliferation via type II CD95 and interleukins. Gastroenterology 2009; 137: 285-96, 296.e1-11 [PMID: 19362089 DOI: 10.1053/ j.gastro.2009.03.061]
58. Ishikawa T, Shibuya K, Yasui K, Mitamura K, Ueda S. Expression of hepatitis C virus core protein associated with malignant lymphoma in transgenic mice. Comp Immunol Microbiol Infect Dis 2003; 26: 115-124 [PMID: 12493492 DOI: 10.1016/S0147-9571(02)00038-3]
59. Kasama Y, Sekiguchi S, Saito M, Tanaka K, Satoh M, Kuwahara K, Sakaguchi N, Takeya M, Hiasa Y, Kohara M, Tsukiyama-Kohara K. Persistent expression of the full genome of hepatitis C virus in B cells induces spontaneous development of B-cell lymphomas in vivo. Blood 2010; 116: 4926-4933 [PMID: 20733156 DOI: 10.1182/blood-2010-05-283358]
60. Accapezzato D, Francavilla V, Paroli M, Casciaro M, Chircu LV, Cividini A, Abrignani S, Mondelli MU, Barnaba V. Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection. J Clin Invest 2004; 113: 963-972 [PMID: 15057302 DOI: 10.1172/ JCI20515]
61. Manigold T, Racanelli V. T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies. Lancet Infect Dis 2007; 7: 804-813 [PMID: 18045563 DOI: 10.1016/S1473-3099(07)70289-X]
62. Blackburn SD, Wherry EJ. IL-10, T cell exhaustion and viral persistence. Trends Microbiol 2007; 15: 143-146 [PMID: 17336072 DOI: 10.1016/j.tim.2007.02.006]
63. Blackburn SD, Crawford A, Shin H, Polley A, Freeman GJ, Wherry EJ. Tissue-specific differences in PD-1 and PD-L1 expression during chronic viral infection: implications for CD8 T-cell exhaustion. J Virol 2010; 84: 2078-2089 [PMID: 19955307 DOI: 10.1128/JVI.01579-09]
64. Jinushi M, Takehara T, Kanto T, Tatsumi T, Groh V, Spies T, Miyagi T, Suzuki T, Sasaki Y, Hayashi N. Critical role of MHC class I-related chain A and B expression on IFN-alphastimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection. J Immunol 2003; 170: 1249-1256 [PMID: 12538683]
65. Jinushi M, Takehara T, Tatsumi T, Kanto T, Miyagi T, Suzuki T, Kanazawa Y, Hiramatsu N, Hayashi N. Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection. J Immunol 2004; 173: 6072-6081 [PMID: 15528343]
66. Kanto T, Hayashi N. Innate immunity in hepatitis C virus infection: Interplay among dendritic cells, natural killer cells and natural killer T cells. Hepatol Res 2007; 37 Suppl 3: S319-S326 [PMID: 17931181 DOI: 10.1111/j.1872034X.2007.00236.x]
67. Kanto T, Hayashi N, Takehara T, Tatsumi T, Kuzushita N, Ito A, Sasaki Y, Kasahara A, Hori M. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol 1999; 162: 5584-5591 [PMID: 10228041]
68. Kanto T, Inoue M, Miyatake H, Sato A, Sakakibara M, Yakushijin T, Oki C, Itose I, Hiramatsu N, Takehara T, Kasahara A, Hayashi N. Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection. J Infect Dis 2004; 190: 1919-1926 [PMID: 15529255 DOI: 10.1086/425425]
69. Dessouki O, Kamiya Y, Nagahama H, Tanaka M, Suzu S, Sasaki Y, Okada S. Chronic hepatitis C viral infection reduces NK cell frequency and suppresses cytokine secretion: Reversion by anti-viral treatment. Biochem Biophys Res Commun 2010; 393: 331-337 [PMID: 20138830 DOI: 10.1016/ j.bbrc.2010.02.008]
70. Bain C, Fatmi A, Zoulim F, Zarski JP, Trépo C, Inchauspé G. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 2001; 120: 512-524 [PMID: 11159892 DOI: 10.1053/gast.2001.21212]
71. Domínguez-Villar M, Muñoz-Suano A, Anaya-Baz B, Aguilar S, Novalbos JP, Giron JA, Rodríguez-Iglesias M, Garcia-Cozar F. Hepatitis C virus core protein up-regulates anergy-related genes and a new set of genes, which affects T cell homeostasis. J Leukoc Biol 2007; 82: 1301-1310 [PMID: 17711976 DOI: 10.1189/jlb.0507335]
72. Crotta S, Brazzoli M, Piccioli D, Valiante NM, Wack A. Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection. J Hepatol 2010; 52: 183-190 [PMID: 20015567 DOI: 10.1016/ j.jhep.2009.11.003]
73. Abe T, Kaname Y, Hamamoto I, Tsuda Y, Wen X, Taguwa S, Moriishi K, Takeuchi O, Kawai T, Kanto T, Hayashi N, Akira S, Matsuura Y. Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines. J Virol 2007; 81: 8953-8966 [PMID: 17567694 DOI: 10.1128/JVI.00649-07]
74. Bergqvist A, Sundström S, Dimberg LY, Gylfe E, Masucci MG. The hepatitis C virus core protein modulates T cell responses by inducing spontaneous and altering T-cell receptor-triggered Ca2+ oscillations. J Biol Chem 2003; 278: 18877-18883 [PMID: 12639962 DOI: 10.1074/jbc.M300185200]
75. Bergqvist A, Rice CM. Transcriptional activation of the interleukin-2 promoter by hepatitis C virus core protein. J Virol 2001; 75: 772-781 [PMID: 11134290 DOI: 10.1128/ JVI.75.2.772-781.2001]
76. Yao ZQ, Eisen-Vandervelde A, Waggoner SN, Cale EM, Hahn YS. Direct binding of hepatitis C virus core to gC1qR on CD4+ and CD8+ T cells leads to impaired activation of Lck and Akt. J Virol 2004; 78: 6409-6419 [PMID: 15163734 DOI: 10.1128/JVI.78.12.6409-6419.2004]
77. Kondo Y, Ueno Y, Wakui Y, Ninomiya M, Kakazu E, Inoue J, Kobayashi K, Obara N, Shimosegawa T. Rapid reduction of hepatitis C virus-Core protein in the peripheral blood improve the immunological response in chronic hepatitis C patients. Hepatol Res 2011; 41: 1153-1168 [PMID: 21951312 DOI: 10.1111/j.1872-034X.2011.00878.x]
78. Kim AY, Schulze zur Wiesch J, Kuntzen T, Timm J, Kaufmann DE, Duncan JE, Jones AM, Wurcel AG, Davis BT, Gandhi RT, Robbins GK, Allen TM, Chung RT, Lauer GM, Walker BD. Impaired hepatitis C virus-specific T cell responses and recurrent hepatitis C virus in HIV coinfection. PLoS Med 2006; 3: e492 [PMID: 17194190 DOI: 10.1371/journal.pmed.0030492]
79. Craxì A, Laffi G, Zignego AL. Hepatitis C virus (HCV) infection: a systemic disease. Mol Aspects Med 2008; 29: 85-95 [PMID: 18177700 DOI: 10.1016/j.mam.2007.09.017]
80. Aceti A, Mangoni ML, Pasquazzi C, Fiocco D, Marangi M, Miele R, Zechini B, Borro M, Versace I, Simmaco M. Alphadefensin increase in peripheral blood mononuclear cells from patients with hepatitis C virus chronic infection. J Viral Hepat 2006; 13: 821-827 [PMID: 17109681 DOI: 10.1111/ j.1365-2893.2006.00762.x]
81. Tacke RS, Tosello-Trampont A, Nguyen V, Mullins DW, Hahn YS. Extracellular hepatitis C virus core protein activates STAT3 in human monocytes/macrophages/dendritic cells via an IL-6 autocrine pathway. J Biol Chem 2011; 286: 10847-10855 [PMID: 21282107 DOI: 10.1074/jbc. M110.217653]